An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program
Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Medical Follow-Up Agency, Institute of Medicine
National Academies Press, Nov 25, 2002 - Medical - 144 pages
In 1998, the Department of Defense (DoD) began a program of mandatory immunization against anthrax for all military personnel. As the program proceeded, however, some military personnel and their families raised concerns about the safety and efficacy of the anthrax vaccine. Acknowledging both the need to protect military personnel and the concerns about the anthrax vaccine, congress directed the Centers for Disease Control and Prevention (CDC) to carry out a research program on its safety and efficacy. To assist in the development of this program, CDC requested the Institute of Medicine (IOM) to convene a committee to review the completeness and appropriateness of the research program. In An Assessment of the CDC Anthrax Vaccine Safety and Efficacy Research Program, the committee makes an overall assessment of the CDD research plan and reviews the specific studies proposed by CDC in the three areas of efficacy, safety and acceptability. The committee also notes additional research needs that became evident following the bioterrorist events of 2001 and makes recommendations about the leadership of the research program.
What people are saying - Write a review
We haven't found any reviews in the usual places.
3 The CDC Anthrax Vaccine Research Plan
4 Proposed Studies on the Efficacy of the Anthrax Vaccine
5 Proposed Studies on the Safety of the Anthrax Vaccine
6 Proposed Studies on the Acceptability of the Anthrax Vaccine
7 Summary Assessment of the CDC Anthrax Vaccine Research Plan
Appendix A Biographical Sketches
Appendix B InformationGathering Meeting Agendas
Appendix C Anthrax Vaccine Safety Efficacy Research Plan
New Drug and Biological Drug Products Evidence Needed to Demonstrate Effectiveness of New Drugs When Human Efficacy Studies Are Not Ethic...
Reintroduction of the Anthrax Vaccine Immunization Program
CDC Anthrax Vaccine Safety Efficacy Research Program Interim Report Findings and Recommendations1
The Anthrax Vaccine Is It Safe? Does It Work? Findings and Recommendations1
Other editions - View all
administration of AVA Adverse Event Reporting adverse events following aluminum hydroxide analysis animals anthracis anthrax spores anthrax vaccine research Anthrax Vaccine Safety antibody appropriate approval assess associated AVA vaccination AVIP Bacillus anthracis biological products CDC Anthrax Vaccine CDC research CDC’s Centers for Disease challenge Chapter civilian committee committee’s concerns conducted congressional mandate Control and Prevention correlates of protection data mining Disease Control DMSS data doses of AVA Eﬂicacy Plan Epidemiology evaluate ﬁndings ﬁrst focus groups health effects human clinical trial hypothesis identiﬁed immune correlates immune response immunogenicity inhalational anthrax Institute of Medicine KABs macrophagic myofasciitis military personnel National Immunization Program occurrence of adverse priority proposed studies reactogenicity receipt of AVA received AVA Recommendation regarding the anthrax research plan rhesus macaques risk factors route of administration safety and efﬁcacy scientiﬁc signiﬁcant speciﬁc subpart survey testing vaccination schedule vaccination with AVA vaccine doses